XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.3Close
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Assets:    
Cash and cash equivalents $ 6,875 $ 8,196
Investments 2,805 3,259
Accounts receivable, net 36,179 35,227
Inventories 17,649 18,025
Other current assets 3,835 3,151
Total current assets 67,343 67,858
Long-term investments 28,939 23,019
Property and equipment, net 12,728 13,183
Operating lease right-of-use assets 16,231 17,252
Goodwill 91,272 91,272
Intangible assets, net 27,817 29,234
Separate accounts assets 3,334 3,250
Other assets 4,763 4,660
Total assets 252,427 249,728 Close
Liabilities:    
Accounts payable 15,713 14,897
Pharmacy claims and discounts payable 23,917 22,874
Health care costs payable 15,237 12,049
Policyholders’ funds 913 1,326
Accrued expenses 20,174 22,189
Other insurance liabilities 1,051 1,141
Current portion of operating lease liabilities 1,912 1,741
Short-term debt 800 200
Current portion of long-term debt 4,910 2,772
Total current liabilities 84,627 79,189
Long-term operating lease liabilities 15,258 16,034
Long-term debt 59,824 58,638
Deferred income taxes 3,632 4,311
Separate accounts liabilities 3,334 3,250
Other long-term insurance liabilities 5,162 5,459
Other long-term liabilities 5,484 6,211
Total liabilities 177,321 173,092 Close
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,777 shares issued and 1,258 shares outstanding at September 30, 2024 and 1,768 shares issued and 1,288 shares outstanding at December 31, 2023 and capital surplus 49,510 48,992
Treasury stock, at cost: 519 shares at September 30, 2024 and 480 shares at December 31, 2023 (36,813) (33,838)
Retained earnings 62,038 61,604
Accumulated other comprehensive income (loss) 209 (297)
Total CVS Health shareholders’ equity 74,944 76,461
Noncontrolling interests 162 175
Total shareholders’ equity 75,106 76,636 Close
Total liabilities and shareholders’ equity $ 252,427 $ 249,728